Table 1.
Factors driven the preference for track 1 among Italian HCPs
| Factors | Pulmonologist (%) | Allergist (%) | GP (%) |
|---|---|---|---|
| Preference for ICS-LABA over SABA | 63.8* | 54.0* | 38.7 |
| Greater compliance for the patient/single device | 58.2* | 62.8* | 39.8 |
| Recommended by guidelines | 44.8* | 38.1 | 29.5 |
| Greater symptom efficacy | 37.7 | 33.6 | 33.3 |
| Greater efficacy in exacerbation control | 37.7* | 35.4 | 26.9 |
| Higher compliance | 35.3 | 41.6 | 40.7 |
| Greater anti-inflammatory action | 29.7* | 27.4 | 22.0 |
| Greater efficacy in airway impairment | 22.0* | 21.2* | 13.5 |
| Patients with mild symptoms | 12.8 | 21.2** | 21.6 |
| Patients with severe symptoms | 9.8* | 12.4* | 6.0 |
| Failure of track 2 | 5.0 | 6.2 | 5.3 |
*Statistically significant compared with GPs (p < 0.05)
**Statistically significant compared with pulmonologists (p < 0.05)